Authors:
Krol, ADG
Le Cessie, S
Snijder, S
Kluin-Nelemans, JC
Kluin, PM
Noordijk, EM
Citation: Adg. Krol et al., Waldeyer's ring lymphomas: A clinical study from the comprehensive cancer center west population based NHL registry, LEUK LYMPH, 42(5), 2001, pp. 1005-1013
Authors:
Krol, ADG
Berenschot, HWA
Doekharan, D
Henzen-Logmans, S
van der Holt, B
van 't Veer, MB
Citation: Adg. Krol et al., Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy andradiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy, RADIOTH ONC, 58(3), 2001, pp. 251-255
Authors:
Hoeve, MA
Krol, ADG
Philippo, K
Derksen, PWB
Veenendaal, RA
Schuuring, E
Kluin, PM
van Krieken, JHJM
Citation: Ma. Hoeve et al., Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction, J CL PATH-M, 53(4), 2000, pp. 194-200
Authors:
van Leeuwen, FE
Klokman, WJ
van't Veer, MB
Hagenbeek, A
Krol, ADG
Vetter, UAO
Schaapveld, M
van Heerde, P
Burgers, JMV
Somers, R
Aleman, BMP
Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497
Authors:
Senan, S
de Koste, JV
Samson, M
Tankink, H
Jansen, P
Nowak, PJCM
Krol, ADG
Schmitz, P
Lagerwaard, FJ
Citation: S. Senan et al., Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer, RADIOTH ONC, 53(3), 1999, pp. 247-255